Table 1.

Baseline Characteristics

Characteristic	Patients With No Prevalent Diabetes (n = 1,310)		Patients With Prevalent Diabetes (n = 210)		P
	No.	%	No.	%
Treatment arm
Arm I	652	50	111	53	.41
Arm II	658	50	99	47
Age, years
< 70	579	44	101	48	.29
≥ 70	731	56	109	52
Race
White	1,120	86	159	76	.001
Black	157	12	40	19
Other	33	3	11	5
Clinical stage
T2	591	45	99	47	.61
T3	670	51	101	48
T4	49	4	10	5
Gleason score
2-6	499	38	83	40	.51
7-10	721	55	117	56
Unknown	90	7	10	5
PSA, ng/mL
≤ 30	867	66	154	73	.041
> 30	443	34	56	27
Median	20.5		18.4
Range	0.1-250		0.9-228.4
Weight, kg
Median	83.6		88.5		< .0001
Range	48.6-173		47-131.3
Unknown	79		18
Tertile 1 (< 78.2 kg)	424	34	46	24	< .0001
Tertile 2 (78.2-89.5 kg)	438	36	55	29
Tertile 3 (> 89.5 kg)	369	30	91	47

Abbreviation: PSA, prostate-specific antigen.